Description
The Finance of Biotech focuses on various aspects of what’s needed for successful fundraising at each stage of company growth. The course addresses some of the common questions around risks of investing, types of investment securities, and differences between private and public markets. John Tagliamonte and Atul Deshpande, CEO’s of biotech startups, respectively, will lead the course with invited guest lecturers from venture capital, private equity, investment banks, and pharmaceutical companies.
Date and Time
Thursday, April 25th, 2025, 9:00 AM – 4:00 PM EST
Please plan to arrive at least 15 minutes before class starts. Class will start at 9:00 AM. We will have breaks in between.
This course will be held in-person. Breakfast and lunch will be provided at this all day workshop.
Topics
- Primary Risks of Biotech Investing
- Starting with Debt and/or Stock Equity, Major Stages of Startup Financing
- Dilutive and Non-Dilutive Funding
- Assessing Your Company’s Value
- Common Types of Investment Securities